<DOC>
	<DOCNO>NCT00611585</DOCNO>
	<brief_summary>The purpose study meet PMA condition approval BHR System . The study evaluate long term safety effectiveness BHR system patient non-inflammatory inflammatory arthritis .</brief_summary>
	<brief_title>A Safety Efficacy Study Birmingham Hip Resurfacing System</brief_title>
	<detailed_description>This post-approval , prospective , non-randomized , longitudinal , unmasked , multi-center , clinical trial design evaluate longer-term safety effectiveness BHR system . The data collect permit clinical evaluation device performance improve hip pain , function range motion ten year . The study permit radiographic evaluation proper component fixation alignment maintenance 10 year post-operative . The incidence revision especially important measure study . Data collect allow analysis implant survivorship .</detailed_description>
	<criteria>At least 21 year age skeletally mature Patients require primary hip resurface due : Noninflammatory arthritis ( degenerative joint disease ) osteoarthritis , traumatic arthritis , avascular necrosis , dysplasia/DDH Inflammatory arthritis rheumatoid arthritis Subject his/her legal guardian willing consent participate study sign date approved consent form Subject available clinical followup least ten year Subject meet none exclusion criterion Subjects infection sepsis Subjects vascular insufficiency , muscular atrophy , neuromuscular disease severe enough compromise implant stability postoperative recovery Female subject childbearing age Subjects bone stock inadequate support device Subjects know moderate severe renal insufficiency Subjects know suspect metal sensitivity ( e.g . jewelry ) Subjects immunosuppressed disease AIDS person receive high dos corticosteroid Subjects psychological neurological condition would preempt ability unwillingness participate study Subjects severely overweight</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>